Cost effectiveness of screening and statin therapy in clinical guidelines for cardiovascular prophylaxis

被引：0
|
作者：
Milne, RJ [1 ]
Gamble, GD [1 ]
机构：
[1] Univ Auckland, Auckland 1, New Zealand
来源：
VALUE IN HEALTH | 2004年 / 7卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)62091-8
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：228 / 228
页数：1
相关论文
共 50 条
  • [41] Cost-Effectiveness of Cardiovascular Screening in Patients With Rheumatoid Arthritis
    Kievit, Wietske
    Maurits, Jake S. F.
    Arts, Elke E.
    van Riel, Piet L. C. M.
    Fransen, Jaap
    Popa, Calin D.
    ARTHRITIS CARE & RESEARCH, 2017, 69 (02) : 175 - 182
  • [42] Cost effectiveness of screening for cardiovascular disease with measures of coronary calcium
    Shaw, LJ
    Raggi, P
    Berman, DS
    Callister, TQ
    PROGRESS IN CARDIOVASCULAR DISEASES, 2003, 46 (02) : 171 - 184
  • [43] Cost Effectiveness of Ezetimibe in Patients with Cardiovascular Disease and Statin Intolerance or Contraindications A Markov Model
    Ara, Roberta
    Pandor, Abdullah
    Tumur, Indra
    Paisley, Suzy
    Duenas, Alejandra
    Williams, Robert
    Rees, Angie
    Wilkinson, Anna
    Durrington, Paul
    Chilcott, Jim
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2008, 8 (06) : 419 - 427
  • [44] Cost Effectiveness of Ezetimibe in Patients with Cardiovascular Disease and Statin Intolerance or ContraindicationsA Markov Model
    Roberta Ara
    Abdullah Pandor
    Indra Tumur
    Suzy Paisley
    Alejandra Duenas
    Robert Williams
    Angie Rees
    Anna Wilkinson
    Paul Durrington
    Jim Chilcott
    American Journal of Cardiovascular Drugs, 2008, 8 : 419 - 427
  • [45] Cost-Effectiveness of Hypertension Therapy According to 2014 Guidelines
    Moran, Andrew E.
    Odden, Michelle C.
    Thanataveerat, Anusorn
    Tzong, Keane Y.
    Rasmussen, Petra W.
    Guzman, David
    Williams, Lawrence
    Bibbins-Domingo, Kirsten
    Coxson, Pamela G.
    Goldman, Lee
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (17): : 1677 - 1677
  • [46] Cost-Effectiveness of Hypertension Therapy According to 2014 Guidelines
    Moran, Andrew E.
    Odden, Michelle C.
    Thanataveerat, Anusorn
    Tzong, Keane Y.
    Rasmussen, Petra W.
    Guzman, David
    Williams, Lawrence
    Bibbins-Domingo, Kirsten
    Coxson, Pamela G.
    Goldman, Lee
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (05): : 447 - 455
  • [47] Cost-effectiveness of statin medications
    Kaplan, RM
    Golomb, BA
    AMERICAN PSYCHOLOGIST, 2001, 56 (04) : 366 - 367
  • [48] Potential cost-effectiveness of C-reactive protein screening followed by targeted statin therapy for the primary prevention of cardiovascular disease among patients without overt hyperlipidemia
    Blake, GJ
    Ridker, PM
    Kuntz, KM
    AMERICAN JOURNAL OF MEDICINE, 2003, 114 (06): : 485 - 494
  • [49] A Look at Statin Cost-Effectiveness in View of the 2013 ACC/AHA Cholesterol Management Guidelines
    Deano, Roderick C.
    Pandya, Ankur
    Jones, Erica C.
    Borden, William B.
    CURRENT ATHEROSCLEROSIS REPORTS, 2014, 16 (09)
  • [50] A Look at Statin Cost-Effectiveness in View of the 2013 ACC/AHA Cholesterol Management Guidelines
    Roderick C. Deaño
    Ankur Pandya
    Erica C. Jones
    William B. Borden
    Current Atherosclerosis Reports, 2014, 16
12345